Saku Biosciences: Funding, Investors & Team (Sep 2026)
Saku Biosciences is an early stage life sciences company that aims to reduce the costs to make biotechnology products.
Saku Biosciences has raised $200k across 1 funding round on record, the most recent a Seed of $200k announced in May 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Saku Biosciences Company Profile and Key Stats
Latest funding round on record: May 2026.
Saku Biosciences Funding Rounds
Saku Biosciences Founders and Leadership Team
Contact details for the Saku Biosciences team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Saku Biosciences Funding Compared to Other Biotechnology Startups
Saku Biosciences' latest round of $200k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Saku Biosciences in Biotechnology and Los Angeles
Companies Similar to Saku Biosciences
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Saku Biosciences Funding FAQs
What does Saku Biosciences do?
Saku Biosciences is an early stage life sciences company that aims to reduce the costs to make biotechnology products.
How much funding has Saku Biosciences raised?
Saku Biosciences has raised $200k across 1 round on record. The most recent is a Seed of $200k announced in May 2026.
When did Saku Biosciences last raise funding?
Saku Biosciences' most recent funding round on record is a Seed of $200k, announced in May 2026.
Who founded Saku Biosciences?
FundedIQ lists Mark Van (Founder) at Saku Biosciences.
Where is Saku Biosciences headquartered?
Saku Biosciences is based in Los Angeles, California, United States.
How many employees does Saku Biosciences have?
Saku Biosciences is in the 1-10 employee band.
How does Saku Biosciences' funding compare to other Biotechnology startups?
Saku Biosciences' latest round of $200k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Saku Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Saku Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.